Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1462074
PUBLISHER: KBV Research | PRODUCT CODE: 1462074
LAMEA Iliac Stent Market Size, Share & Trends Analysis Report By Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions), By End-use, By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Latin America, Middle East and Africa Iliac Stent Market would witness market growth of 8.7% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA Iliac Stent Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $26.7 million by 2030. The Argentina market is showcasing a CAGR of 9.4% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 8.4% during (2023 - 2030).
The applications of iliac stent procedures span a broad spectrum of vascular conditions, encompassing the management of peripheral artery disease (PAD), iliac artery aneurysms, traumatic injuries, and complex vascular pathologies. These procedures are commonly used to manage peripheral artery disease (PAD) affecting the iliac arteries. Plaque accumulation in the arteries, which results in decreased blood flow to the lower limbs, is a hallmark of PAD.
Iliac stenting can improve perfusion to the affected limb, promote wound healing, and reduce the risk of amputation in patients with advanced vascular disease. Additionally, these can treat iliac artery aneurysms, which are abnormal dilations or bulges in the iliac arteries. Stenting of iliac artery aneurysms can help prevent the risk of rupture, thrombosis, and embolization, particularly in high-risk patients or those with large or symptomatic aneurysms.
Saudi Arabia's high healthcare costs reflect its dedication to providing its people with high-quality healthcare services. This includes investment in advanced medical technologies and infrastructure. According to the International Trade Administration data, Saudi Arabia contributes 60% of the healthcare expenditures of the Gulf Cooperation Council (GCC) nations, and the Saudi Arabian government continues to prioritize this sector. Thus, the expansion of the region's healthcare sector is propelling the market's growth.
Based on Artery Lesions, the market is segmented into Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. Based on End-use, the market is segmented into Hospitals, Outpatient Facilities, and Others. Based on Type, the market is segmented into Self-expandable Stents, Balloon-expandable Stents, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Becton, Dickinson and Company
- Abbott Laboratories
- Boston Scientific Corporation
- W. L. Gore & Associates, Inc.
- Medtronic PLC
- Cook Medical, Inc.(Cook Group)
- Terumo Corporation
- iVascular S.L.U.
- Getinge AB
- Biotronik SE & Co. KG
LAMEA Iliac Stent Market Report Segmentation
By Artery Lesions
- Common Iliac Artery Lesions
- Severe Calcified Lesions
- Complete Obstructive Lesions
By End-use
- Hospitals
- Outpatient Facilities
- Others
By Type
- Self-expandable Stents
- Balloon-expandable Stents
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1LAMEA Iliac Stent Market, by Artery Lesions
- 1.4.2LAMEA Iliac Stent Market, by End-use
- 1.4.3LAMEA Iliac Stent Market, by Type
- 1.4.4LAMEA Iliac Stent Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.LAMEA Iliac Stent Market by Artery Lesions
- 4.1LAMEA Common Iliac Artery Lesions Market by Country
- 4.2LAMEA Severe Calcified Lesions Market by Country
- 4.3LAMEA Complete Obstructive Lesions Market by Country
Chapter 5.LAMEA Iliac Stent Market by End-use
- 5.1LAMEA Hospitals Market by Country
- 5.2LAMEA Outpatient Facilities Market by Country
- 5.3LAMEA Others Market by Country
Chapter 6.LAMEA Iliac Stent Market by Type
- 6.1LAMEA Self-expandable Stents Market by Country
- 6.2LAMEA Balloon-expandable Stents Market by Country
- 6.3LAMEA Others Market by Country
Chapter 7.LAMEA Iliac Stent Market by Country
- 7.1Brazil Iliac Stent Market
- 7.1.1Brazil Iliac Stent Market by Artery Lesions
- 7.1.2Brazil Iliac Stent Market by End-use
- 7.1.3Brazil Iliac Stent Market by Type
- 7.2Argentina Iliac Stent Market
- 7.2.1Argentina Iliac Stent Market by Artery Lesions
- 7.2.2Argentina Iliac Stent Market by End-use
- 7.2.3Argentina Iliac Stent Market by Type
- 7.3UAE Iliac Stent Market
- 7.3.1UAE Iliac Stent Market by Artery Lesions
- 7.3.2UAE Iliac Stent Market by End-use
- 7.3.3UAE Iliac Stent Market by Type
- 7.4Saudi Arabia Iliac Stent Market
- 7.4.1Saudi Arabia Iliac Stent Market by Artery Lesions
- 7.4.2Saudi Arabia Iliac Stent Market by End-use
- 7.4.3Saudi Arabia Iliac Stent Market by Type
- 7.5South Africa Iliac Stent Market
- 7.5.1South Africa Iliac Stent Market by Artery Lesions
- 7.5.2South Africa Iliac Stent Market by End-use
- 7.5.3South Africa Iliac Stent Market by Type
- 7.6Nigeria Iliac Stent Market
- 7.6.1Nigeria Iliac Stent Market by Artery Lesions
- 7.6.2Nigeria Iliac Stent Market by End-use
- 7.6.3Nigeria Iliac Stent Market by Type
- 7.7Rest of LAMEA Iliac Stent Market
- 7.7.1Rest of LAMEA Iliac Stent Market by Artery Lesions
- 7.7.2Rest of LAMEA Iliac Stent Market by End-use
- 7.7.3Rest of LAMEA Iliac Stent Market by Type
Chapter 8.Company Profiles
- 8.1Becton, Dickinson, and Company
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5Recent strategies and developments:
- 8.1.5.1Trials and Approvals:
- 8.1.6SWOT Analysis
- 8.2Abbott Laboratories
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5SWOT Analysis
- 8.3Boston Scientific Corporation
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Segmental and Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5Recent strategies and developments:
- 8.3.5.1Trials and Approvals:
- 8.3.6SWOT Analysis
- 8.4W. L. Gore & Associates, Inc.
- 8.4.1Company Overview
- 8.4.2SWOT Analysis
- 8.5Medtronic PLC
- 8.5.1Company overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5Recent strategies and developments:
- 8.5.5.1Trials and Approvals:
- 8.5.6SWOT Analysis
- 8.6Cook Medical, Inc. (Cook Group)
- 8.6.1Company Overview
- 8.6.2SWOT Analysis
- 8.7Terumo Corporation
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5Recent strategies and developments:
- 8.7.5.1Trials and Approvals:
- 8.7.5.2Product Launches and Product Expansions:
- 8.7.6SWOT Analysis
- 8.8iVascular S.L.U.
- 8.8.1Company Overview
- 8.8.2SWOT Analysis
- 8.9Getinge AB
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expense
- 8.9.5Recent strategies and developments:
- 8.9.5.1Trials and Approvals:
- 8.9.6SWOT Analysis
- 8.10.Biotronik SE & Co. KG
- 8.10.1Company Overview
- 8.10.2SWOT Analysis
LIST OF TABLES
- TABLE 1LAMEA Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 2LAMEA Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 3LAMEA Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 4LAMEA Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 5LAMEA Common Iliac Artery Lesions Market by Country, 2019 - 2022, USD Million
- TABLE 6LAMEA Common Iliac Artery Lesions Market by Country, 2023 - 2030, USD Million
- TABLE 7LAMEA Severe Calcified Lesions Market by Country, 2019 - 2022, USD Million
- TABLE 8LAMEA Severe Calcified Lesions Market by Country, 2023 - 2030, USD Million
- TABLE 9LAMEA Complete Obstructive Lesions Market by Country, 2019 - 2022, USD Million
- TABLE 10LAMEA Complete Obstructive Lesions Market by Country, 2023 - 2030, USD Million
- TABLE 11LAMEA Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 12LAMEA Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 13LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
- TABLE 14LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
- TABLE 15LAMEA Outpatient Facilities Market by Country, 2019 - 2022, USD Million
- TABLE 16LAMEA Outpatient Facilities Market by Country, 2023 - 2030, USD Million
- TABLE 17LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 18LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 19LAMEA Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 20LAMEA Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 21LAMEA Self-expandable Stents Market by Country, 2019 - 2022, USD Million
- TABLE 22LAMEA Self-expandable Stents Market by Country, 2023 - 2030, USD Million
- TABLE 23LAMEA Balloon-expandable Stents Market by Country, 2019 - 2022, USD Million
- TABLE 24LAMEA Balloon-expandable Stents Market by Country, 2023 - 2030, USD Million
- TABLE 25LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 26LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 27LAMEA Iliac Stent Market by Country, 2019 - 2022, USD Million
- TABLE 28LAMEA Iliac Stent Market by Country, 2023 - 2030, USD Million
- TABLE 29Brazil Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 30Brazil Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 31Brazil Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 32Brazil Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 33Brazil Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 34Brazil Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 35Brazil Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 36Brazil Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 37Argentina Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 38Argentina Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 39Argentina Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 40Argentina Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 41Argentina Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 42Argentina Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 43Argentina Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 44Argentina Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 45UAE Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 46UAE Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 47UAE Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 48UAE Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 49UAE Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 50UAE Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 51UAE Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 52UAE Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 53Saudi Arabia Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 54Saudi Arabia Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 55Saudi Arabia Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 56Saudi Arabia Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 57Saudi Arabia Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 58Saudi Arabia Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 59Saudi Arabia Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 60Saudi Arabia Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 61South Africa Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 62South Africa Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 63South Africa Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 64South Africa Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 65South Africa Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 66South Africa Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 67South Africa Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 68South Africa Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 69Nigeria Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 70Nigeria Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 71Nigeria Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 72Nigeria Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 73Nigeria Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 74Nigeria Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 75Nigeria Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 76Nigeria Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 77Rest of LAMEA Iliac Stent Market, 2019 - 2022, USD Million
- TABLE 78Rest of LAMEA Iliac Stent Market, 2023 - 2030, USD Million
- TABLE 79Rest of LAMEA Iliac Stent Market by Artery Lesions, 2019 - 2022, USD Million
- TABLE 80Rest of LAMEA Iliac Stent Market by Artery Lesions, 2023 - 2030, USD Million
- TABLE 81Rest of LAMEA Iliac Stent Market by End-use, 2019 - 2022, USD Million
- TABLE 82Rest of LAMEA Iliac Stent Market by End-use, 2023 - 2030, USD Million
- TABLE 83Rest of LAMEA Iliac Stent Market by Type, 2019 - 2022, USD Million
- TABLE 84Rest of LAMEA Iliac Stent Market by Type, 2023 - 2030, USD Million
- TABLE 85Key Information - Becton, Dickinson and Company
- TABLE 86Key Information - Abbott Laboratories
- TABLE 87Key Information - Boston Scientific Corporation
- TABLE 88Key Information - W. L. Gore & Associates, Inc.
- TABLE 89Key Information - Medtronic PLC
- TABLE 90Key Information - Cook Medical, Inc.
- TABLE 91Key Information - Terumo Corporation
- TABLE 92Key Information - iVascular S.L.U.
- TABLE 93Key Information - Getinge AB
- TABLE 94Key Information - Biotronik SE & Co. KG
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.